2017
DOI: 10.1002/ange.201611078
|View full text |Cite
|
Sign up to set email alerts
|

A Double Allylation Strategy for Gram‐Scale Guaianolide Production: Total Synthesis of (+)‐Mikanokryptin

Abstract: With over 5000 members isolated to date, sesquiterpene lactones represent a prolific source of medicinal agents with several derivatives in human clinical trials. The guaianolides, a major subset of this group, have been intensely investigated from both medicinal and chemical synthesis perspectives for decades. To date, the myriad stereochemical permutations presented by this enormous family have precluded the synthesis of many unique members. Herein we report the first total synthesis of the trans-fused 8,12-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 81 publications
(24 reference statements)
0
5
0
Order By: Relevance
“…Antibodies were obtained from Cell Signaling Technologies unless otherwise noted. Mikanokryptin was synthesized as previously described (Hu et al, 2017). Synthesis and characterization of cysteine-reactive covalent ligands screened against FAK1 were either described previously or described in Supporting Methods (Bateman et al, 2017;Grossman et al, 2017;Roberts et al, 2017b).…”
Section: Methods Details Chemicalsmentioning
confidence: 99%
See 1 more Smart Citation
“…Antibodies were obtained from Cell Signaling Technologies unless otherwise noted. Mikanokryptin was synthesized as previously described (Hu et al, 2017). Synthesis and characterization of cysteine-reactive covalent ligands screened against FAK1 were either described previously or described in Supporting Methods (Bateman et al, 2017;Grossman et al, 2017;Roberts et al, 2017b).…”
Section: Methods Details Chemicalsmentioning
confidence: 99%
“…Consistent with these results, parthenolide, costunolide, and dehydrocostus lactone, but not a-santonin, exhibited FAK1 cysteine reactivity as shown by competitive IA-rhodamine labeling of FAK1 (Figure 3B). Moreover, the more highly oxidized guaianolide sesquiterpene mikanokryptin (Hu et al, 2017), which also possesses differing stereochemistry relative to dehydrocostus lactone, also showed FAK1 cysteine reactivity and impaired 231MFP breast cancer cell proliferation and survival (Figures 3C-3E). Taken together, these findings indicate some flexibility in targeting this druggable hotspot with sesquiterpene natural products harboring reactive a-methylene-g-butyrolactone homo-Michael acceptors.…”
Section: In Briefmentioning
confidence: 99%
“…3B). Moreover, the more highly oxidized guaianolide sesquiterpene mikanokryptin (Hu et al, 2017), which also possesses differing stereochemistry relative to dehydrocostus lactone, also showed FAK1 cysteine reactivity and impaired 231MFP breast cancer cell proliferation and survival ( Fig. 3C-E).…”
Section: Main Textmentioning
confidence: 99%
“…Antibodies were obtained from Cell Signaling Technologies unless otherwise noted. Mikanokryptin was synthesized as previously described (Hu et al, 2017). Synthesis and characterization of cysteine-reactive covalent ligands screened against FAK1 were either described previously or described in Supporting Methods Grossman et al, 2017;Roberts et al, 2017b).…”
Section: Chemicalsmentioning
confidence: 99%
“…Notably, the total synthesis of sesquiterpenes and SLs has led to intense research efforts for decades; however, only a few unified synthetic protocols have been published to analyze the diverse carbocyclic complexity presented by the sesquiterpenoid family (20,21,40,41). Furthermore, despite extensive studies on the chemical synthesis and biology of 6,12-SLs, the isomeric 8,12-SLs, comprising almost half of the natural substances, have received relatively limited attention in the pharmacological field, restricting the identification of the pharmacological potential of this family of compounds (42). Thus, efforts to improve our understanding of the molecular mechanisms underlying the effects of SLs in cancer cells are urgently required to ensure the clinical exploitation and application of these compounds as potential anticancer therapeutic agents.…”
Section: Discussionmentioning
confidence: 99%